We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Opexa Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $134K → $0 (-$134K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
California Public Employees Retirement System
California Public Employees Retirement System
California
-$29K
2
TSS
Two Sigma Securities
New York
-$20K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
– -$29K -266,050 Closed
TSS
2
Two Sigma Securities
New York
– -$20K -181,400 Closed
Bank of New York Mellon
3
Bank of New York Mellon
New York
– -$6K -50,000 Closed

OPXAW Hedge Fund Activity: Q3 2017 in Review

0 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q3 2017, worth a combined $0 — down 100% from $134K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OPXAW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $29K sold.

  • 0 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q3 2017, down from 4 in Q2 2017.
  • Funds reported $0 of Opexa Therapeutics, Inc. stock for Q3 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Opexa Therapeutics, Inc. positions in Q3 2017 and 3 closed out, a net change of -3 holders.
  • The largest Opexa Therapeutics, Inc. seller in Q3 2017 was California Public Employees Retirement System, an estimated $29K sold.

Based on aggregated 13F filings for Q3 2017.